
Written and medically reviewed by Dr Alireza Salehzadeh, GP, Hinchley Medical.
BMI is often treated as a fixed number that defines health. In reality, its meaning changes significantly as we age. What is considered a “healthy” BMI at 25 may not be appropriate at 65 — and focusing on the wrong target can sometimes increase, rather than reduce, cardiovascular risk.
Modern clinical guidance increasingly emphasises individualised weight targets, balancing BMI with blood pressure, cholesterol, blood sugar and overall cardiovascular health. Understanding how BMI should be interpreted across different life stages is essential for safe, effective and evidence-based weight management.
BMI alone does not define health. NICE guidance highlights the importance of assessing overall cardiovascular risk, including blood pressure, cholesterol, insulin resistance and fat distribution.
At Hinchley Medical, Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescribed as part of a clinician-led, NICE-aligned weight-management programme.
BMI is calculated in the same way throughout adulthood, but its clinical interpretation changes with age due to changes in muscle mass, fat distribution and overall cardiovascular risk.
For many adults over 65, a BMI between 23 and 29 may be appropriate, provided muscle mass, nutrition and functional ability are maintained.
NICE supports their consideration for adults with obesity, or overweight with related health conditions, when delivered as part of a supervised medical weight-management programme.